- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
This entry looks at primary B cell cutaneous lymphoma, one of the subtypes of lymphoma. 'Lymphoma' is an umbrella term that loosely refers to several dozen independent categorical types and subtypes of cancers of the lymphatic system.
And of course there are a few more, including primary B cell cutaneous lymphoma, in which B cell lymphocytes in the skin become cancerous.
Primary B cell cutaneous lymphoma is a non-Hodgkin's lymphoma the origin of which is in the skin (thus the term 'primary'). If the disease spread to the skin from a different primary site, it would be considered secondary B cell cutaneous lymphoma and therefore a systemic disease. This however is extremely rare; it is exceedingly more common for primary B cell cutaneous lymphoma.
Initial treatment for lower-stage primary B cell cutaneous lymphoma will involve at least one or more of the following therapuetic options:
In general, primary B cell cutaneous lymphoma has an excellent prognosis, with a high cure rate (around 90%) when the appropriate treatment option is used. Although prognosis is very good, recurrence is not uncommon.